Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT06684613 · Yale University

Integrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics

What this study is about

This study addresses the need for HIV prevention to be integrated into counseling visits at sexual and reproductive health clinics.

View original scientific description

This study addresses the need for HIV prevention to be integrated into counseling visits at sexual and reproductive health clinics.

Interventions

DEVICE

PrEP Decision Aid

Patient-facing decision-aid on PrEP that will be enhanced to include various formulations of available PrEP. Can be integrated into sexual and reproductive health clinics as part of counseling.

OTHER

Generic Information

Participants will be asked to watch a CDC-produced video, "PrEP (Pre-Exposure Prophylaxis" (available online free of charge through the CDC web site). The video will serve as a time- and attention- based control to the decision aid.

Primary outcome measures

PrEP initiation (prescribing)

Time frame: 6 months

Whether PrEP was prescribed (yes/no) in the EHR within the 6-month time frame

Feasibility of implementing the enhanced PrEP decision aid in SRH settings, according to the Proctor taxonomy

Time frame: 6 months

Feasibility is defined as the extent to which the enhanced PrEP decision aid can be successfully used in SRH clinic settings (qualitative).

Acceptability of the enhanced PrEP decision aid within SRH settings, according to users (Proctor taxonomy)

Time frame: 6 months

Acceptability is defined as the user perception that the enhanced PrEP decision aid is acceptable in SRH settings.

Penetration (reach) of the enhanced decision aid within SRH clinics (Proctor taxonomy)

Time frame: 6 months

Penetration (reach) of the intervention, measured by recruitment rate (number of participants enrolled per month)

Penetration (reach) of the enhanced decision aid within SRH clinics (Proctor taxonomy)

Time frame: 6 months

Penetration (reach) of the intervention, measured by completion rate (percentage of participants completing 6-month interviews out of those enrolled)

Penetration (reach) of the enhanced decision aid within SRH clinics (Proctor taxonomy)

Time frame: 6 months

Penetration (reach) of the intervention, measured by reasons for not meeting inclusion criteria

Adoption of the enhanced PrEP decision aid within SRH settings, according to users (Proctor taxonomy)

Time frame: 6 months

Adoption of the enhanced decision aid into SRH clinics, assessed by whether PrEP was discussed during the visit (yes/no)

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Aged 18 years or older
  • Have a uterus
  • Do not have HIV (by self-report)
  • Not currently on PrEP
  • Comfortable conversing in English or Spanish
  • Able to participate in informed consent procedures Patients (

Exclusion criteria

  • People who cannot become pregnant (i.e., have had a hysterectomy or tubal ligation)
  • People who wish to become pregnant (will not qualify for pregnancy prevention counseling)
  • Have a scheduled visit with a member of the investigative team (to minimize risk of potential ascertainment bias)
  • Participants of Aim 1 cannot participate in Aim 2. Sexual and Reproductive Health clinicians will be included if they provide sexual and reproductive health patient care at any of the participating sites. Clinic staff will be included if they work at any of the participating sites and have patient-facing or non-patient-facing roles .

Where

  • New Haven, Connecticut

Collaborators

National Institute of Mental Health (NIMH)

Related conditions & keywords

Sexual Risk Behavior for HIV-infectionReproductive HealthHIV PreventionPrEPsexual reproductive healthwoman

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Mar 19, 2026 · Source of record for eligibility and locations

📊
1 of 50 participants interested
2% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

New Haven

Connecticut

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More HIV AIDS Trials by City

Browse all hiv aids clinical trials in these cities — not just this study.

Browse More Trials by Condition

Looking for Sexual Risk Behavior for HIV-infection Treatment in New Haven?

Join others in Connecticut exploring innovative treatment options through clinical research

Sexual Risk Behavior for HIV-infection Treatment Options in New Haven, Connecticut

If you're searching for Sexual Risk Behavior for HIV-infection treatment in New Haven, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in New Haven and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Sexual Risk Behavior for HIV-infection. All study-related care is provided at no cost to participants.

Local Sites
1 locations in Connecticut
Now Enrolling
Up to 50 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Sexual Risk Behavior for HIV-infection?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Sexual Risk Behavior for HIV-infection

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Sexual Risk Behavior for HIV-infection Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06684613. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.